查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医疗对策市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2023年～2030年)- 各产品，各用途，各地区(北美，欧洲，亚太地区，南美，中东·非洲)
市场调查报告书
商品编码
1312416

医疗对策市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2023年～2030年)- 各产品，各用途，各地区(北美，欧洲，亚太地区，南美，中东·非洲)

Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 220 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于对经济实惠且有效的药物的需求不断增长，以应对不确定的疫情，全球医疗响应市场的规模正在医疗保健行业实现飞跃。由于需要强有力且有针对性的医疗干预措施来维持医护人员的努力并防止疾病传播，药物安全保障市场正在朝着显着增长的方向发展。

本报告提供全球医疗对策市场相关调查，提供市场概要，以及各类型，各产品，各用途，向各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 法律规范
  • 政府的配合措施投资
  • 技术的进步
  • 大环境分析
  • 价值链分析
  • COVID-19影响分析

第3章 全球医疗对策市场预测，2018年～2030年

  • 全球医疗对策市场预测，各类型，2018年～2030年
  • 全球医疗对策市场预测，各产品，2018年～2030年
  • 全球医疗对策市场预测，各用途，2018年～2030年
  • 全球医疗对策市场预测，各地区，2018年～2030年

第4章 北美的医疗对策市场预测，2018年～2030年

第5章 欧洲的医疗对策市场预测，2018年～2030年

第6章 亚太地区的医疗对策市场预测，2018年～2030年

第7章 南美的医疗对策市场预测，2018年～2030年

第8章 中东·非洲的医疗对策市场预测，2018年～2030年

第9章 竞争情形

  • 市场占有率分析
  • 企业简介
    • Pfizer, Inc.
    • Altimmune, Inc.
    • SIGA Technologies
    • Bavarian Nordic A/S
    • Dynavax Technologies Corporation
    • National Resilience, Inc.
    • GSK plc
    • Xoma Corporation
    • Meridian Medical Technologies, LLC
    • Bruker Detection
    • Ichor Medical Systems
    • Teledyne Technologies, Inc.
    • 其他

第10章 附录

简介目录

The global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical countermeasures to sustain the efforts of healthcare workers and prevent the spread of diseases, the market is advancing towards significant growth in the safety assurance of drugs.

Growing Demand for Medical Countermeasures in the Face of Uncertain Outbreaks

Healthcare providers are increasingly relying on medical countermeasures to address the uncertainty of outbreaks and ensure accessible medicines with fewer side effects upon successful diagnosis. The availability of extensive vaccines or antivirals that are unapproved can lead to ineffective treatments, undermining efforts to produce safe and effective drugs. To maintain consistent efforts in healthcare and prevent diseases from spreading, the demand for robust and suitable medical countermeasures has risen incessantly.

Rigorous Quality Checks and Clinical Trials Enhance Market Potential

Before entering the market, drugs undergo rigorous quality checks and clinical trials to ensure their safety and efficacy. Government agencies like the U.S. Food and Drug Administration (FDA) pre-evaluate medications sold in the market, further assuring safety to consumers. These stringent quality checks, coupled with growing awareness of medical countermeasures and unpredictable outbreaks, are expected to expand the dimensions of the medical countermeasures market and boost sales in the coming years.

Rising Prevalence of Infectious Diseases and Advancements in Precision Medicines Propel Market Growth

The medical countermeasures market, comprising medical devices and therapeutic products, is dominated by vaccines, particularly due to the prevalence of infectious diseases like HIV/AIDS. The market is witnessing continuous growth as an increasing number of patients require life-saving vaccines to combat lethal diseases such as dengue and influenza virus (H1N1). Advancements in personalized medicine and Matrix Metalloproteinases (MMPs) are also expected to drive market expansion. Additionally, rising awareness about countermeasures to combat biological agents further boosts the momentum for the medical countermeasures market.

Asia Pacific Emerges as a Promising Market with Robust Investments in Research & Development

While the U.S. leads the global medical countermeasures market with strict norms and regulations on drug development and rising awareness about bioterrorism attacks, Asia Pacific is poised to demonstrate substantial growth during the forecast period. The region's market is influenced by increasing biological warfare threats and growing investments in research and development by key players to develop countermeasures against bio aggressors. Moreover, the region's sophisticated infrastructure and government investments in the latest countermeasures and R&D contribute to market growth.

Leading Players Shaping the Global Medical Countermeasures Market

Some of the prominent players operating in the global medical countermeasures market include: Sanofi Pasteur, Johnson & Johnson, CSL Limited, GlaxoSmithKline plc, Pfizer, Inc., Emergent BioSolutions, Inc., Daiichi Sankyo Company, Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bavarian Nordic, AstraZeneca, Bharat Biotech, Incepta Vaccine Ltd., Biological E, Sinovac Biotech Ltd., Valneva SE, PT Bio Farma, Panacea Biotec, and VBI Vaccines Inc.

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Countermeasures Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Medical Countermeasures Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Opportunities
      • 2.2.3.1. Opportunity 1
      • 2.2.3.2. Opportunity 2
  • 2.3. Regulatory Framework
  • 2.4. Government Initiatives and Investments
  • 2.5. Technological Advancements
  • 2.6. PESTLE Analysis
  • 2.7. Value Chain Analysis
  • 2.8. COVID-19 Impact Analysis

3. Global Medical Countermeasures Market Outlook, 2018 - 2030

  • 3.1. Global Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 3.1.1. Key Highlights
    • 3.1.2. Global Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 3.1.2.1. Drugs
      • 3.1.2.2. Biologics
      • 3.1.2.3. Devices
    • 3.1.3. Global Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
    • 3.1.4. Global Medical Countermeasures Market Attractiveness Analysis, by Type, 2023 - 2030
  • 3.2. Global Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 3.2.1. Key Highlights
    • 3.2.2. Global Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 3.2.2.1. Diagnostic
      • 3.2.2.2. Therapeutic
      • 3.2.2.3. Prophylactic
    • 3.2.3. Global Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
    • 3.2.4. Global Medical Countermeasures Market Attractiveness Analysis, By Product, 2023 - 2030
  • 3.3. Global Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 3.3.1. Key Highlights
    • 3.3.2. Global Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 3.3.2.1. Small pox
      • 3.3.2.2. Anthrax
      • 3.3.2.3. Botulism
      • 3.3.2.4. Chemical Threat
      • 3.3.2.5. Radiological/Nuclear Threat
      • 3.3.2.6. Emerging Infectious Diseases
      • 3.3.2.7. Others
    • 3.3.3. Global Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
    • 3.3.4. Global Medical Countermeasures Market Attractiveness Analysis, by Application, 2023 - 2030
  • 3.4. Global Medical Countermeasures Market Outlook, By Region, 2018 - 2030
    • 3.4.1. Key Highlights
    • 3.4.2. Global Medical Countermeasures Market Outlook, by Region, Value (US$ Million), 2018 - 2030
      • 3.4.2.1. North America
      • 3.4.2.2. Europe
      • 3.4.2.3. Asia Pacific
      • 3.4.2.4. Latin America
      • 3.4.2.5. Middle East & Africa
    • 3.4.3. Global Medical Countermeasures Market Share and BPS Analysis, by Region, 2023 and 2030
    • 3.4.4. Global Medical Countermeasures Market Attractiveness Analysis, by Region, 2023 - 2030

4. North America Medical Countermeasures Market Outlook, 2018 - 2030

  • 4.1. North America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 4.1.1. Key Highlights
    • 4.1.2. North America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 4.1.2.1. Drugs
      • 4.1.2.2. Biologics
      • 4.1.2.3. Devices
    • 4.1.3. North America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 4.2. North America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 4.2.1. Key Highlights
    • 4.2.2. North America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 4.2.2.1. Diagnostic
      • 4.2.2.2. Therapeutic
      • 4.2.2.3. Prophylactic
    • 4.2.3. North America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 4.3. North America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 4.3.1. Key Highlights
    • 4.3.2. North America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 4.3.2.1. Small pox
      • 4.3.2.2. Anthrax
      • 4.3.2.3. Botulism
      • 4.3.2.4. Chemical Threat
      • 4.3.2.5. Radiological/ Nuclear Threat
      • 4.3.2.6. Emerging Infectious Diseases
      • 4.3.2.7. Others
    • 4.3.3. North America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 4.4. North America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 4.4.1. Key Highlights
    • 4.4.2. North America Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 4.4.2.1. U.S.
      • 4.4.2.2. Canada
    • 4.4.3. North America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

5. Europe Medical Countermeasures Market Outlook, 2018 - 2030

  • 5.1. Europe Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 5.1.1. Key Highlights
    • 5.1.2. Europe Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 5.1.2.1. Drugs
      • 5.1.2.2. Biologics
      • 5.1.2.3. Devices
    • 5.1.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 5.2. Europe Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 5.2.1. Key Highlights
    • 5.2.2. Europe Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 5.2.2.1. Diagnostic
      • 5.2.2.2. Therapeutic
      • 5.2.2.3. Prophylactic
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 5.3. Europe Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 5.3.1. Key Highlights
    • 5.3.2. Europe Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 5.3.2.1. Small pox
      • 5.3.2.2. Anthrax
      • 5.3.2.3. Botulism
      • 5.3.2.4. Chemical Threat
      • 5.3.2.5. Radiological/Nuclear Threat
      • 5.3.2.6. Emerging Infectious Diseases
      • 5.3.2.7. Others
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 5.4. Europe Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 5.4.1. Key Highlights
    • 5.4.2. Europe Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 5.4.2.1. Germany
      • 5.4.2.2. France
      • 5.4.2.3. U.K.
      • 5.4.2.4. Italy
      • 5.4.2.5. Spain
      • 5.4.2.6. Russia
      • 5.4.2.7. Rest of Europe
    • 5.4.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

6. Asia Pacific Medical Countermeasures Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 6.1.1. Key Highlights
    • 6.1.2. Asia Pacific Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 6.1.2.1. Drugs
      • 6.1.2.2. Biologics
      • 6.1.2.3. Devices
    • 6.1.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 6.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 6.2.1. Key Highlights
    • 6.2.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 6.2.2.1. Diagnostic
      • 6.2.2.2. Therapeutic
      • 6.2.2.3. Prophylactic
    • 6.2.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 6.3. Asia Pacific Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 6.3.1. Key Highlights
    • 6.3.2. Asia Pacific Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 6.3.2.1. Small pox
      • 6.3.2.2. Anthrax
      • 6.3.2.3. Botulism
      • 6.3.2.4. Chemical Threat
      • 6.3.2.5. Radiological/Nuclear Threat
      • 6.3.2.6. Emerging Infectious Diseases
      • 6.3.2.7. Others
    • 6.3.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 6.4. Asia Pacific Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 6.4.1. Key Highlights
    • 6.4.2. Asia Pacific Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 6.4.2.1. Japan
      • 6.4.2.2. China
      • 6.4.2.3. India
      • 6.4.2.4. Australia & New Zealand
      • 6.4.2.5. South Korea
      • 6.4.2.6. Rest of Asia Pacific
    • 6.4.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

7. Latin America Medical Countermeasures Market Outlook, 2018 - 2030

  • 7.1. Latin America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 7.1.1. Key Highlights
    • 7.1.2. Latin America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 7.1.2.1. Drugs
      • 7.1.2.2. Biologics
      • 7.1.2.3. Devices
    • 7.1.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 7.2. Latin America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 7.2.1. Key Highlights
    • 7.2.2. Latin America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 7.2.2.1. Diagnostic
      • 7.2.2.2. Therapeutic
      • 7.2.2.3. Prophylactic
    • 7.2.3. Latin America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 7.3. Latin America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 7.3.1. Key Highlights
    • 7.3.2. Latin America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 7.3.2.1. Small pox
      • 7.3.2.2. Anthrax
      • 7.3.2.3. Botulism
      • 7.3.2.4. Chemical Threat
      • 7.3.2.5. Radiological/Nuclear Threat
      • 7.3.2.6. Emerging Infectious Diseases
      • 7.3.2.7. Others
    • 7.3.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 7.4. Latin America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 7.4.1. Key Highlights
    • 7.4.2. Latin America Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 7.4.2.1. Brazil
      • 7.4.2.2. Mexico
      • 7.4.2.3. Argentina
      • 7.4.2.4. Rest of Latin America
    • 7.4.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

8. Middle East & Africa Medical Countermeasures Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Medical Countermeasures Market Outlook, Type, 2018 - 2030
    • 8.1.1. Key Highlights
    • 8.1.2. Middle East & Africa Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 8.1.2.1. Drugs
      • 8.1.2.2. Biologics
      • 8.1.2.3. Devices
    • 8.1.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 8.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 8.2.1. Key Highlights
    • 8.2.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 8.2.2.1. Diagnostic
      • 8.2.2.2. Therapeutic
      • 8.2.2.3. Prophylactic
    • 8.2.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 8.3. Middle East & Africa Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 8.3.1. Key Highlights
    • 8.3.2. Middle East & Africa Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 8.3.2.1. Small pox
      • 8.3.2.2. Anthrax
      • 8.3.2.3. Botulism
      • 8.3.2.4. Chemical Threat
      • 8.3.2.5. Radiological/Nuclear Threat
      • 8.3.2.6. Emerging Infectious Diseases
      • 8.3.2.7. Others
    • 8.3.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 8.4. Middle East & Africa Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 8.4.1. Key Highlights
    • 8.4.2. Middle East & Africa Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 8.4.2.1. Saudi Arabia
      • 8.4.2.2. UAE
      • 8.4.2.3. South Africa
      • 8.4.2.4. Rest of Middle East & Africa
    • 8.4.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

9. Competitive Landscape

  • 9.1. Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1. Pfizer, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Portfolio
      • 9.2.1.4. Recent Developments
    • 9.2.2. Altimmune, Inc.
    • 9.2.3. SIGA Technologies
    • 9.2.4. Bavarian Nordic A/S
    • 9.2.5. Dynavax Technologies Corporation
    • 9.2.6. National Resilience, Inc.
    • 9.2.7. GSK plc
    • 9.2.8. Xoma Corporation
    • 9.2.9. Meridian Medical Technologies, LLC
    • 9.2.10. Bruker Detection
    • 9.2.11. Ichor Medical Systems
    • 9.2.12. Teledyne Technologies, Inc.
    • 9.2.13. Others

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Specific Research Approach
  • 10.3. Acronyms and Abbreviations